Affordable Health Care for Every American
Peter strongly believes that every American has a right to affordable health care. He is fighting to cut the skyrocketing cost of prescription drugs and advance cost-effective telemedicine technology.
- Pass Medicare for All
- Allow the importation of safe prescription drugs from Canada
- Cut the cost of prescription drugs for seniors by using Medicare’s purchasing power to demand a better deal from drug companies
- Remove barriers to the development of low cost generic drugs
- Block any attempt to overturn Roe v. Wade and repeal the Hyde Amendment
- Fully fund Planned Parenthood and Title X family planning services
- Provide significant resources to communities on the front lines of opioid epidemic
- Increase funding for NIH disease and drug research
More on Affordable Health Care for Every American
BURLINGTON – At a press conference today at Community Health Centers of Burlington, Rep.
WASHINGTON—Rep. Peter Welch (D-Vt.) and Rep. David McKinley (R-W.Va.) today introduced the Fair Access for Safe and Timely (FAST) Generics Act. The legislation would thwart manipulation of the Food and Drug Administration’s (FDA) drug safety regulations in order to block the production of generic alternatives to brand name medicines. This would increase consumer access to generic drugs, boost market competition, and ultimately save consumers money. The FAST Generics Act is cosponsored by Rep. David Cicilline (D-R.I.).
WASHINGTON — Members of Congress from both parties served notice on pharmaceutical companies on Tuesday that the days of unchecked drug-price increases were over and that they would be held politically accountable for exorbitant prices.
The new reality became apparent at simultaneous but separate hearings of House and Senate committees where lawmakers said that the relentless increases were unsustainable and unacceptable.
WASHINGTON, D.C. – Reps. Peter Welch (D-Vt.) and Morgan Griffith (R-Va.) today reintroduced the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act. The legislation would ensure that community pharmacists receive reimbursement at the rate posted at the time prescriptions are filled by prohibiting Medicare Part D plan sponsors and pharmacy benefit managers (PBMs) from retroactively reducing payments on accurate reimbursement claims submitted by pharmacies.
WASHINGTON - Rep. Peter Welch (D-Vt.) has been reappointed to the House Committee on Oversight and Reform. The committee has broad jurisdiction over executive branch programs and activities. Welch has served on the committee since he was first elected to Congress in 2006.
WASHINGTON – Reps. Peter Welch (D-Vt.) and Francis Rooney (R-Fla.) sent a letter late Friday to federal regulators demanding scrutiny of the impact on consumers of the pending merger of two pharmaceutical giants, Celgene and Bristol-Myers Squibb.
WASHINGTON – Rep. Peter Welch (D-Vt.), Rep. Francis Rooney (R-Fla.) and nine House colleagues today introduced bipartisan legislation that would require the federal government to negotiate lower drug prices for seniors enrolled in the Medicare Part D program.
A divided Congress probably won’t be able to agree on much over the next two years. But that vacuum could bode well for one vexing problem both parties say they want to solve: the high cost of prescription drugs in the United States.
Hope is strong among health-care advocates and lawmakers that 2019 could be the year Congress and the executive branch finally make significant moves against the powerful prescription drug industry, after long acknowledging a need for action but doing little about it.
Prescription drug companies and their legions of Washington lobbyists are strapping in for their rockiest year on Capitol Hill in at least a decade, as newly empowered House Democrats prepare a raft of bills to check U.S. drug prices.
Democrats surged to power in the 2018 midterm House elections promising to protect Americans from ever-increasing prescription costs. They are buoyed by populist anger in individual states and a potential — if unpredictable — ally on the issue in the White House.
WASHINGTON, D.C. – This week, the House passed legislation introduced by Rep. Peter Welch (D-Vt.) that closes a loophole in the federal Medicaid program exploited by drug companies to minimize drug discounts required for participation in the program.